Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effexor XR recurrence prevention in MDD
NCT00878748Phase 4Withdrawn
- Sponsor
- Pfizer
- Start
- Apr 2009
- Primary completion
- Oct 2011
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of venlafaxine in major depressive disorder (MDD), sponsored by Pfizer. Planned start Apr 2009; status: withdrawn.
02
Drugs
venlafaxine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00878748.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00878748.